Danazol/NN
decreases/VBZ
transcription/NN
of/IN
estrogen/NN
receptor/NN
gene/NN
in/IN
human/JJ
monocytes/NNS
./.

1./LS
Administration/NN
of/IN
danazol/NN
for/IN
over/IN
one/CD
month/NN
reduced/VBD
the/DT
levels/NNS
of/IN
estrogen/NN
receptor/NN
(/(
ER/NN
)/)
and/CC
its/PRP$
mRNA/NN
to/TO
approximately/RB
50/CD
and/CC
20/CD
%/NN
,/,
respectively/RB
in/IN
monocytes/NNS
./.
=====
2./LS
Danazol/NN
did/VBD
not/RB
alter/VB
the/DT
degradation/NN
rate/NN
of/IN
ER/NN
mRNA/NN
in/IN
monocytes/NNS
./.
=====
3./LS
Danazol/NN
decreased/VBD
the/DT
transcription/NN
rate/NN
of/IN
ER/NN
gene/NN
to/TO
approximately/RB
50/CD
%/NN
in/IN
monocytes/NNS
in/IN
a/DT
run-on/JJ
assay/NN
./.
=====
4./LS
Danazol/NN
may/MD
release/VB
estrogen/NN
predominance/NN
via/IN
the/DT
reduction/NN
of/IN
transcription/NN
for/IN
ER/NN
gene/NN
,/,
which/WDT
leads/VBZ
to/TO
the/DT
reduction/NN
of/IN
ER/NN
mRNA/NN
and/CC
ER/NN
expressions/NNS
in/IN
monocytes/NNS
./.